AAA gains European approval for Lutathera® for GEP-NET – Completes First Theragnostic Radiopharmaceutical Pairing in Oncology
The European Commission has approved the marketing authorization of Lutetium (177Lu) oxodotreotide (Lutathera) for the treatment of unresectable or metastatic,...
3 October 2017